211 related articles for article (PubMed ID: 11249057)
41. Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: a new highly active chemotherapeutic regimen.
Gebbia V; Testa A; Borsellino N; Ferrera P; Tirrito M; Palmeri S
Ann Oncol; 2001 Jun; 12(6):767-72. PubMed ID: 11484950
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method.
Dieras V; Extra JM; Bellissant E; Espie M; Morvan F; Pierga JY; Mignot L; Tresca P; Marty M
J Clin Oncol; 1996 Dec; 14(12):3097-104. PubMed ID: 8955654
[TBL] [Abstract][Full Text] [Related]
43. Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer.
Nolè F; Crivellari D; Mattioli R; Pinotti G; Foa P; Verri E; Fougeray R; Brandely M; Goldhirsch A
Cancer Chemother Pharmacol; 2009 Sep; 64(4):673-80. PubMed ID: 19184601
[TBL] [Abstract][Full Text] [Related]
44. Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines.
Berruti A; Bitossi R; Gorzegno G; Bottini A; Generali D; Milani M; Katsaros D; Rigault de la Longrais IA; Bellino R; Donadio M; Ardine M; Bertetto O; Danese S; Sarobba MG; Farris A; Lorusso V; Dogliotti L
Br J Cancer; 2005 Feb; 92(4):634-8. PubMed ID: 15668714
[TBL] [Abstract][Full Text] [Related]
45. Phase II study with cisplatin and paclitaxel in combination with weekly high-dose 24 h infusional 5-fluorouracil/leucovorin for first-line treatment of metastatic breast cancer.
Klaassen U; Wilke H; Weyhofen R; Harstrick A; Eberhardt W; Müller C; Korn M; Hanske M; Diergarten K; Seeber S
Anticancer Drugs; 1998 Mar; 9(3):203-7. PubMed ID: 9625430
[TBL] [Abstract][Full Text] [Related]
46. Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study.
Pectasides D; Pectasides M; Farmakis D; Bountouroglou N; Nikolaou M; Koumpou M; Mylonakis N; Kosmas C
Ann Oncol; 2003 Apr; 14(4):537-42. PubMed ID: 12649097
[TBL] [Abstract][Full Text] [Related]
47. Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer.
Nolè F; Catania C; Sanna G; Imadalou K; Munzone E; Adamoli L; Longerey B; Blanchot G; Goldhirsch A
Ann Oncol; 2006 Feb; 17(2):322-9. PubMed ID: 16303864
[TBL] [Abstract][Full Text] [Related]
48. Vinorelbine, epirubicin and fluorouracil as first-line therapy in metastatic breast cancer--a phase II trial.
Elomaa I; Joensuu H; Blomqvist C
Acta Oncol; 2003; 42(4):309-14. PubMed ID: 12899502
[TBL] [Abstract][Full Text] [Related]
49. Phase II study of cisplatin and 5-fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185).
Kucuk O; Pandya KJ; Skeel RT; Hochster H; Abeloff MD
Breast Cancer Res Treat; 1999 Sep; 57(2):201-6. PubMed ID: 10598047
[TBL] [Abstract][Full Text] [Related]
50. Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale).
Lorusso V; Spada M; Giampaglia M; Misino A; Calabrese R; Latorre A; Monticelli G; Guida M; Sambiasi D; Colucci G;
Ann Oncol; 2006 Jun; 17 Suppl 7():vii15-7. PubMed ID: 16760280
[TBL] [Abstract][Full Text] [Related]
51. Combination cisplatin-vinorelbine for relapsed and chemotherapy-pretreated metastatic breast cancer.
Shamseddine AI; Taher A; Dabaja B; Dandashi A; Salem Z; El Saghir NS
Am J Clin Oncol; 1999 Jun; 22(3):298-302. PubMed ID: 10362341
[TBL] [Abstract][Full Text] [Related]
52. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
[TBL] [Abstract][Full Text] [Related]
53. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
[TBL] [Abstract][Full Text] [Related]
54. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.
Hansen RM; Ryan L; Anderson T; Krzywda B; Quebbeman E; Benson A; Haller DG; Tormey DC
J Natl Cancer Inst; 1996 May; 88(10):668-74. PubMed ID: 8627643
[TBL] [Abstract][Full Text] [Related]
55. Infusional 5-FU, folinic acid, paclitaxel, and cisplatin for metastatic breast cancer.
Klaassen U; Wilke H; Müller C; Borquez D; Korn M; Achterrath W; Harstrick A; Diergarten K; Seeber S
Oncology (Williston Park); 1997 Apr; 11(4 Suppl 3):38-40. PubMed ID: 9144690
[TBL] [Abstract][Full Text] [Related]
56. Low-dose continuous intravenous infusion of 5-fluorouracil for metastatic breast cancer.
Regazzoni S; Pesce G; Marini G; Cavalli F; Goldhirsch A
Ann Oncol; 1996 Oct; 7(8):807-13. PubMed ID: 8922194
[TBL] [Abstract][Full Text] [Related]
57. A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer.
Farhat FS; Temraz S; Kattan J; Ibrahim K; Bitar N; Haddad N; Jalloul R; Hatoum HA; Nsouli G; Shamseddine AI
Clin Breast Cancer; 2011 Dec; 11(6):384-9. PubMed ID: 21993011
[TBL] [Abstract][Full Text] [Related]
58. Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study.
Oliva C; Bergnolo P; Inguì M; Bianco L; Pochettino P; Cutin SC; Boglione A; Dal Canton O; Garetto F; Comandone A
J Cancer Res Clin Oncol; 2010 Mar; 136(3):411-7. PubMed ID: 19727815
[TBL] [Abstract][Full Text] [Related]
59. Activity and safety of vinorelbine combined with doxorubicin or fluorouracil as first-line therapy in advanced breast cancer: a stratified phase II study.
Hochster HS; Vogel CL; Burman SL; White R
Oncologist; 2001; 6(3):269-77. PubMed ID: 11423674
[TBL] [Abstract][Full Text] [Related]
60. Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN).
Nolè F; Minchella I; Colleoni M; Orvieto E; Munzone E; de Braud F; Peruzzotti G; Martinelli G; Zampino MG; Catania C; Pizzamiglio M; Veronesi P; Zurrida S; Galimberti V; Goldhirsch A; Veronesi U
Ann Oncol; 1999 Aug; 10(8):993-6. PubMed ID: 10509165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
